UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The effect of ethnicity and genetic ancestry on the epidemiology, clinical features and outcome of systemic lupus erythematosus

Rheumatology (Oxford, England), 2017-04, Vol.56 (suppl_1), p.i67-i77

2017

Volltextzugriff (PDF)

The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults: Executive Summary

Rheumatology (Oxford, England), 2018-01, Vol.57 (1), p.14-18

2018

Volltextzugriff (PDF)

Classifying and diagnosing systemic lupus erythematosus in the 21st century

Rheumatology (Oxford, England), 2020-12, Vol.59 (Supplement_5), p.v4-v11

2020

Volltextzugriff (PDF)

The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults

Rheumatology (Oxford, England), 2018-01, Vol.57 (1), p.e1-e45

2018

Volltextzugriff (PDF)

Systemic lupus erythematosus diagnosis and management

Rheumatology (Oxford, England), 2017-04, Vol.56 (suppl_1), p.i3-i13

2017

Volltextzugriff (PDF)

Both prolonged remission and Lupus Low Disease Activity State are associated with reduced damage accrual in systemic lupus erythematosus

Rheumatology (Oxford, England), 2017-01, Vol.56 (1), p.121-128

2017

Volltextzugriff (PDF)

Damage accrual and mortality over long-term follow-up in 300 patients with systemic lupus erythematosus in a multi-ethnic British cohort

Rheumatology (Oxford, England), 2020-03, Vol.59 (3), p.524-533

2020

Volltextzugriff (PDF)

Prevalence of systemic lupus erythematosus in Spain: higher than previously reported in other countries?

Rheumatology (Oxford, England), 2020-09, Vol.59 (9), p.2556-2562

2020

Volltextzugriff (PDF)

Development and validation of a new algorithm for attribution of neuropsychiatric events in systemic lupus erythematosus

Rheumatology (Oxford, England), 2015-05, Vol.54 (5), p.891-898

2015

Volltextzugriff (PDF)

Phase 2, randomized, placebo-controlled trial of dapirolizumab pegol in patients with moderate-to-severe active systemic lupus erythematosus

Rheumatology (Oxford, England), 2021-11, Vol.60 (11), p.5397-5407

2021

Volltextzugriff (PDF)

PD-1+CXCR5−CD4+T cells are correlated with the severity of systemic lupus erythematosus

Rheumatology (Oxford, England), 2019-12, Vol.58 (12), p.2188-2192

2019

Volltextzugriff (PDF)

New biomarkers in SLE: from bench to bedside

Rheumatology (Oxford, England), 2020-12, Vol.59 (Supplement_5), p.v12-v18

2020

Volltextzugriff (PDF)

Low-dose glucocorticoids should be withdrawn or continued in systemic lupus erythematosus? A systematic review and meta-analysis on risk of flare and damage accrual

Rheumatology (Oxford, England), 2021-12, Vol.60 (12), p.5517-5526

2021

Volltextzugriff (PDF)

Treatment targets in SLE: remission and low disease activity state

Rheumatology (Oxford, England), 2020-12, Vol.59 (Supplement_5), p.v19-v28

2020

Volltextzugriff (PDF)

Pathways leading to an immunological disease: systemic lupus erythematosus

Rheumatology (Oxford, England), 2017-04, Vol.56 (suppl_1), p.i55-i66

2017

Volltextzugriff (PDF)

The prevention, screening and treatment of congenital heart block from neonatal lupus: a survey of provider practices

Rheumatology (Oxford, England), 2018-07, Vol.57 (suppl_5), p.v9-v17

2018

Volltextzugriff (PDF)

The impact of social determinants of health on the presentation, management and outcomes of systemic lupus erythematosus

Rheumatology (Oxford, England), 2023-03, Vol.62 (Supplement_1), p.i10-i14

2023

Volltextzugriff (PDF)

Type I interferon-mediated autoimmune diseases: pathogenesis, diagnosis and targeted therapy

Rheumatology (Oxford, England), 2017-10, Vol.56 (10), p.1662

2017

Volltextzugriff (PDF)

Risk of thrombosis with anti-phospholipid syndrome in systemic lupus erythematosus treated with thrombopoietin-receptor agonists

Rheumatology, 2018-08, Vol.57 (8), p.1432-1438

2018

Volltextzugriff (PDF)

Long-term safety and limited organ damage in patients with systemic lupus erythematosus treated with belimumab: a Phase III study extension

Rheumatology (Oxford, England), 2020-02, Vol.59 (2), p.281-291

2020

Volltextzugriff (PDF)

Identification of highly active systemic lupus erythematosus by combined type I interferon and neutrophil gene scores vs classical serologic markers

Rheumatology, 2020-11, Vol.59 (11), p.3468-3478

2020

Volltextzugriff (PDF)

Ultrasound to identify systemic lupus erythematosus patients with musculoskeletal symptoms who respond best to therapy: the US Evaluation For mUsculoskeletal Lupus longitudinal multicentre study

Rheumatology (Oxford, England), 2021-11, Vol.60 (11), p.5194-5204

2021

Volltextzugriff (PDF)

Hydroxychloroquine reduces risk of incident diabetes mellitus in lupus patients in a dose-dependent manner: a population-based cohort study

Rheumatology (Oxford, England), 2015-07, Vol.54 (7), p.1244-1249

2015

Volltextzugriff (PDF)

Obinutuzumab induces superior B-cell cytotoxicity to rituximab in rheumatoid arthritis and systemic lupus erythematosus patient samples

Rheumatology (Oxford, England), 2017-07, Vol.56 (7), p.1227-1237

2017

Volltextzugriff (PDF)

Mortality, causes of death and influence of medication use in patients with systemic lupus erythematosus vs matched controls

Rheumatology (Oxford, England), 2021-01, Vol.60 (1), p.207-216

2021

Volltextzugriff (PDF)

1 – 25 von 1.197

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieRheumatology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.196)
Mit Volltextzugriff
(1.117)

Publikationsform

Artikel
(1.197)

Sprache

Englisch
(1.197)

Erscheinungsjahr

n.n

Thema

Rheumatology
(1.033)
Life Sciences & Biomedicine
(1.030)
Science & Technology
(1.030)
Humans
(995)
Female
(679)
Systemic Lupus Erythematosus
(601)
Adult
(570)
Male
(506)
Middle Aged
(436)
Biological And Medical Sciences
(386)
Medical Sciences
(386)
Lupus Erythematosus, Systemic - Complications
(300)
Lupus Erythematosus, Systemic - Immunology
(237)
Diseases Of The Osteoarticular System
(230)
Lupus Erythematosus, Systemic - Drug Therapy
(230)
Sle
(188)
Severity Of Illness Index
(186)
Adolescent
(175)
Aged
(172)
Young Adult
(148)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

2 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

1 weiteren anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The effect of ethnicity and genetic ancestry on the epidemiology, clinical features and outcome of systemic lupus erythematosus

The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults: Executive Summary

Classifying and diagnosing systemic lupus erythematosus in the 21st century

The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults

Systemic lupus erythematosus diagnosis and management

Both prolonged remission and Lupus Low Disease Activity State are associated with reduced damage accrual in systemic lupus erythematosus

Damage accrual and mortality over long-term follow-up in 300 patients with systemic lupus erythematosus in a multi-ethnic British cohort

Prevalence of systemic lupus erythematosus in Spain: higher than previously reported in other countries?

Development and validation of a new algorithm for attribution of neuropsychiatric events in systemic lupus erythematosus

Phase 2, randomized, placebo-controlled trial of dapirolizumab pegol in patients with moderate-to-severe active systemic lupus erythematosus

PD-1+CXCR5−CD4+T cells are correlated with the severity of systemic lupus erythematosus

New biomarkers in SLE: from bench to bedside

Low-dose glucocorticoids should be withdrawn or continued in systemic lupus erythematosus? A systematic review and meta-analysis on risk of flare and damage accrual

Treatment targets in SLE: remission and low disease activity state

Pathways leading to an immunological disease: systemic lupus erythematosus

The prevention, screening and treatment of congenital heart block from neonatal lupus: a survey of provider practices

The impact of social determinants of health on the presentation, management and outcomes of systemic lupus erythematosus

Type I interferon-mediated autoimmune diseases: pathogenesis, diagnosis and targeted therapy

Risk of thrombosis with anti-phospholipid syndrome in systemic lupus erythematosus treated with thrombopoietin-receptor agonists

Long-term safety and limited organ damage in patients with systemic lupus erythematosus treated with belimumab: a Phase III study extension

Identification of highly active systemic lupus erythematosus by combined type I interferon and neutrophil gene scores vs classical serologic markers

Ultrasound to identify systemic lupus erythematosus patients with musculoskeletal symptoms who respond best to therapy: the US Evaluation For mUsculoskeletal Lupus longitudinal multicentre study

Hydroxychloroquine reduces risk of incident diabetes mellitus in lupus patients in a dose-dependent manner: a population-based cohort study

Obinutuzumab induces superior B-cell cytotoxicity to rituximab in rheumatoid arthritis and systemic lupus erythematosus patient samples

Mortality, causes of death and influence of medication use in patients with systemic lupus erythematosus vs matched controls

Aktive Filter

Suchergebnisse filtern